BPG is committed to discovery and dissemination of knowledge
Cited by in F6Publishing
For: Abughanimeh O, Qasrawi A, Kaddourah O, Al Momani L, Abu Ghanimeh M. Clostridium difficile infection in oncology patients: epidemiology, pathophysiology, risk factors, diagnosis, and treatment. Hosp Pract (1995) 2018;46:266-77. [PMID: 30296190 DOI: 10.1080/21548331.2018.1533673] [Cited by in Crossref: 6] [Cited by in F6Publishing: 6] [Article Influence: 1.5] [Reference Citation Analysis]
Number Citing Articles
1 Cornely OA, Mullane KM, Birch T, Hazan-Steinberg S, Nathan R, Bouza E, Calfee DP, Ellison MC, Wong MT, Dorr MB. Exploratory Evaluation of Bezlotoxumab on Outcomes Associated With Clostridioides difficile Infection in MODIFY I/II Participants With Cancer. Open Forum Infect Dis 2020;7:ofaa038. [PMID: 32099847 DOI: 10.1093/ofid/ofaa038] [Cited by in Crossref: 2] [Cited by in F6Publishing: 3] [Article Influence: 1.0] [Reference Citation Analysis]
2 Ma Z, Zhang GL, Gadi MR, Guo Y, Wang P, Li L. Clostridioides difficile cd2775 Encodes a Unique Mannosyl-1-Phosphotransferase for Polysaccharide II Biosynthesis. ACS Infect Dis 2020;6:680-6. [PMID: 32073825 DOI: 10.1021/acsinfecdis.9b00494] [Cited by in Crossref: 3] [Cited by in F6Publishing: 3] [Article Influence: 1.5] [Reference Citation Analysis]
3 Mendelsohn RB, Kaltsas A, King S, Hwang C, Kassam Z, Abend AM, Kramer E, Kamboj M. Fecal Microbiota Transplantation Is Safe for Clostridiodies difficile Infection in Patients with Solid Tumors Undergoing Chemotherapy. Dig Dis Sci 2021. [PMID: 34089134 DOI: 10.1007/s10620-021-07024-z] [Reference Citation Analysis]
4 Milenković B, Šuljagić V, Perić A, Dragojević-Simić V, Tarabar O, Milanović M, Putić V, Tomić D, Miljković B, Vezmar Kovačević S. Outcomes of Clostridioides difficile infection in adult cancer and non-cancer patients hospitalised in a tertiary hospital: a prospective cohort study. Eur J Hosp Pharm 2021:ejhpharm-2020-002574. [PMID: 33579720 DOI: 10.1136/ejhpharm-2020-002574] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 1.0] [Reference Citation Analysis]
5 Buchrits S, Gafter-Gvili A, Bishara J, Atamna A, Ayada G, Eynath Y, Avni T. The Importance of Abnormal Platelet Count in Patients with Clostridioides difficile Infection. J Clin Med 2021;10:2957. [PMID: 34209348 DOI: 10.3390/jcm10132957] [Reference Citation Analysis]
6 Yepez Guevara EA, Aitken SL, Olvera AV, Carlin L, Fernandes KE, Bhatti MM, Garey KW, Adachi J, Okhuysen PC. Clostridioides difficile Infection in Cancer and Immunocompromised Patients: Relevance of a Two-step Diagnostic Algorithm and Infecting Ribotypes on Clinical Outcomes. Clin Infect Dis 2021;72:e460-5. [PMID: 32803229 DOI: 10.1093/cid/ciaa1184] [Reference Citation Analysis]
7 Kubeček O, Paterová P, Novosadová M. Risk Factors for Infections, Antibiotic Therapy, and Its Impact on Cancer Therapy Outcomes for Patients with Solid Tumors. Life (Basel) 2021;11:1387. [PMID: 34947918 DOI: 10.3390/life11121387] [Reference Citation Analysis]